SGL-TX-MR Study: The acute effect of SGLT2i on kidney transplant oxygen levels.
- Conditions
- Kidney transplant recipients
- Registration Number
- 2024-513765-40-00
- Lead Sponsor
- Odense University Hospital
- Brief Summary
To evaluate the acute effect of SGLT2i on kidney allograft oxygen tension in cortex and medulla.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing, recruitment ended
- Sex
- Not specified
- Target Recruitment
- 8
-
Written informed consent must be provided before participation
-
Male or female patients ≥ 18 years of age
-
Non-diabetic kidney transplant recipients, > 6 months post-transplant
-
Stable eGFR> 20 ml/min (stable defined as eGFR 20 ml/min ± 5 ml/min variation in the last 3 months)
-
Tacrolimus(Adport) and Mycophenolatmofetile (Myfenax, cellcept) as part of immunosuppressive treatment
-
Diabetic kidney disease type 1 or 2 (World Health Organization (WHO) criteria)
-
Renal allograft failure (eGFR< 20 ml/min)
-
Alanine aminotransferase (ALAT) > 3 x upper normal limit or bilirubin > 2 x upper normal limit
-
Pregnancy or breastfeeding
-
Exclusion criteria for MRI o Claustrophobia/physical not able to lie in MR-scanner for 2 hours o MRI safety hazards such as cardiac pacemaker, implantable cardioverter defibrillator (ICD), non-MRI compatible implants and implanted devices, intraorbital or intracranial metallic foreign bodies.
-
Allergy towards SGLT2i or the content substance
-
Known intestinal bowel disease
-
Prednisone treatment
Study & Design
- Study Type
- Not specified
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method • Kidney allograft cortical and medullary oxygen tension, estimated by BOLD-MRI based renal T2* relaxation rate. • Kidney allograft cortical and medullary oxygen tension, estimated by BOLD-MRI based renal T2* relaxation rate.
- Secondary Outcome Measures
Name Time Method • Renal cortical and medullary perfusion ml/100 g/min • Renal cortical and medullary perfusion ml/100 g/min
• Renal artery blood flow ml/min • Renal artery blood flow ml/min
• Blood glucose mmol/L • Blood glucose mmol/L
• Systolic blood pressure (SysBP) and diastolic blood pressure (DiaBP) mmHg • Systolic blood pressure (SysBP) and diastolic blood pressure (DiaBP) mmHg
• Heart rate (HR), beats min-1 • Heart rate (HR), beats min-1
Trial Locations
- Locations (1)
Odense University Hospital
🇩🇰Odense C, Denmark
Odense University Hospital🇩🇰Odense C, DenmarkLotte Borg LangeSite contact+4540863392Lotte.Borg.Lange@rsyd.dk